Quick Order Cart

Cat. No. ARG40213

DZANK1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The DZANK1 Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout cell population targeting DZANK1 in human HEK293T cells. DZANK1, a predicted ankyrin repeat and zinc finger domain-containing scaffold protein, is implicated in transcriptional regulation and genetically associated with schizophrenia. Knockout of DZANK1 enables analysis of its contribution to protein interaction networks and gene expression programs, using techniques such as co-immunoprecipitation, RNA-seq, and flow cytometry. This model supports functional studies of ankyrin repeat proteins and zinc finger transcription factors, facilitating research into the molecular basis of schizophrenia.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    DZANK1

    Gene Identifier

    NCBI Gene ID 55184

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DZANK1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the DZANK1 gene in human HEK293T embryonic kidney cells. This polyclonal format delivers a heterogeneous loss-of-function model, enabling robust investigation of DZANK1??s biological roles without the constraints of clonal selection.

HEK293T cells are a human embryonic kidney epithelial line stably expressing the SV40 large T antigen, facilitating episomal replication of plasmids with the SV40 origin. Their high transfectability and capacity for high-level protein expression and viral vector production make them a standard platform for functional genomics, gene-editing applications, and interaction studies.

DZANK1 encodes a protein harboring tandem ankyrin repeats and zinc finger domains, suggesting a scaffold or adapter function in protein?Cprotein interactions and transcriptional regulation. The protein is predicted to interact with ankyrin repeat domain-containing proteins and zinc finger transcription factors, thereby modulating transcriptional regulatory complexes. Although direct interacting partners remain uncharacterized, its domain architecture positions DZANK1 within networks that control gene expression, consistent with GWAS associations linking the gene to schizophrenia and neurodevelopmental disorders.

Knockout of DZANK1 in HEK293T cells disrupts these putative interaction networks, offering a tractable system to dissect its contribution to transcriptional programs and protein interaction landscapes. The HEK293T background provides a neutral, non-neuronal context ideal for isolating DZANK1??s intrinsic biochemical functions. This model supports mechanistic studies relevant to schizophrenia research and the broader understanding of scaffold proteins in gene regulation.

Applications include co-immunoprecipitation for mapping interactomes, Western blotting and RT-qPCR for expression analysis, RNA-seq for transcriptome profiling, and flow-cytometric assessment of apoptosis and proliferation. These assays facilitate functional characterization of ankyrin and zinc finger proteins and exploration of schizophrenia-associated mechanisms. For additional information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)